Security key
107930109
- Security type / class
- Equity / NULL
- Total 13F shares
- 391,323
- Total 13F value
- $452,034
- Share change
- -118,594
- Put/Call ratio
- 7.8%
- SEC-reported price per share
- $1.14
- Number of holders
- 20
- Value change
- -$344,113
- Number of buys
- 8
- Number of sells
- 8
Open additional details 1 more signal available
Report period
Q2 2024
Institutions
20
Top holders
10
BCTX full security history
Ownership snapshot
Full 13F holder table
BriaCell Therapeutics Corp. SEC filings
BriaCell Therapeutics Corp. company facts
Broader feeds
Ownership snapshot
Top reported holders of BCTX - BriaCell Therapeutics Corp. - NULL (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Marc Lustig
Disclosed value leader
Marc Lustig
Comparable rows
0/15
Latest evidence
14 May 2024
3/4/5
13F
Highest disclosed value: $5,632,601
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Marc Lustig has the largest disclosed position value at $5.63M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Marc Lustig's linked filing trail.
Disclosed position value
Top 5
Marc Lustig
$5.63M
Lynwood Capital Management Inc.
$4.57M
Jamieson Bondarenko
$777.9K
BANK OF MONTREAL /CAN/
$520.5K
ARMISTICE CAPITAL, LLC
$510K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Marc Lustig |
3/4/5
Director, 10%+ Owner
|
—
mixed-class rows
|
$5,632,601
3,445,870 shares
mixed-class rows
|
— | 14 May 2024 |
| Lynwood Capital Management Inc. |
13F
Company
|
—
denominator unverified
|
$4,569,565
1,597,750 shares
|
— | 31 Mar 2024 |
| Jamieson Bondarenko |
3/4/5
Chairman, Director
|
—
denominator unverified
|
$777,940
169,856 shares
|
— | 28 Dec 2022 |
| BANK OF MONTREAL /CAN/ |
13F
Company
|
—
denominator unverified
|
$520,526
134,241 shares
|
— | 31 Mar 2024 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$510,000
375,000 shares
|
— | 31 Mar 2024 |
| Redmond Asset Management, LLC |
13F
Company
|
—
mixed-class rows
|
$478,077
208,069 shares
mixed-class rows
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
20
Shares
391,323
Rows available
20
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
16
Q2 2024 holders
20
Holder diff
4
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|